Organisation
Department of Pharmaceutics
Department
Current researchers
1 - 10 of 114 results
- Chris Vervaet (Responsible)
- Justine Aelvoet (Member)
- Ilke Aernout (Member)
- Amin Ahmad (Member)
- Mohsin Ali (Member)
- Ruben Almey (Member)
- Dominika Berdecka (Member)
- Danique Berrevoet (Member)
- Louis Bouckaert (Member)
- Kevin Braeckmans (Member)
Projects
1 - 10 of 380
- Design and synthesis of inhibitors of the MEP pathwayFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- Unraveling the role of the immune system in the development of exuberant granulation tissue in horse woundsFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- LNP-DECODE: Deciphering the adjuvants activity of lipid nanoparticle-based mRNA vaccines in primary dendritic cellsFrom1 Jan 2024 → TodayFunding: BOF - projects
- Restoring fertility by the 3R-approach : rejuvenating, replacing or reconstructing the oocyteFrom1 Jan 2024 → TodayFunding: BOF - projects
- Cofunding core facility - ProGenTomicsFrom1 Dec 2023 → TodayFunding: BOF - research organisations
- Analysis and prevention of protein particle formation – An approach towards safer antibody drugs in the clinicFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- 3D printing of personalized pharmaceutical tablets using different feedstock materials via direct extrusion additive manufacturingFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Engineering of universal iPSC-derived therapeutic cells by nanofiber photoporation.From1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- MATRACs / Membrane Anchoring Trafficking ChimerasFrom1 Nov 2023 → TodayFunding: FWO fellowships
- ILM photodisruption: a biophotonic approach to promote retinal ganglion cell engraftment as a cure for blindnessFrom1 Nov 2023 → TodayFunding: FWO senior postdoctoral fellowship
Publications
1 - 10 of 1873
- The bovine CD1D gene has an unusual gene structure and is expressed but cannot present U+03B1-galactosylceramide with a C26 fatty acid(2013)
Authors: Kim Anh Nguyen Thi, Ad P Koets, Martin Vordermeier, Peter J Jervis, Liam R Cox, Simon P Graham, Wiebren J Santema, D Branch Moody, Serge Van Calenbergh, Dirk M Zajonc, et al.
Pages: 91 - 98 - Drug design and identification of potent leads against Mycobacterium tuberculosis thymidine monophosphate kinase(2012)
Authors: Serge Van Calenbergh, S Pocet, H Munier-Lehmann
Pages: 694 - 705 - Towards new antimalarial drugs: Synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors(2008)
Authors: D Giessmann, P Heidler, Timothy Haemers, Serge Van Calenbergh, A Reichenberg, H Jomaa, C Weidemeyer, S Sanderbrand, J Wiesner, A Link
Pages: 653 - 656 - Receptor-mediated targeting of cathepsins in professional antigen presenting cells(2009)
Authors: Wrik Hillaert, Martijn Verdoes, Bogdan I Florea, Athanasios Saragliadis, Kim LL Habets, Johan Kuiper, Serge Van Calenbergh, Ferry Ossendorp, Gijsbrecht A van der Marel, Christoph Driessen, et al.
Pages: 1629 - 1632 - Engineering the thermostability of sucrose phosphorylase for industrial applications(2011)
Authors: An Cerdobbel
- Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD(2013)
Authors: David Price, Barbara Yawn, Guy Brusselle, Andrea Rossi
Pages: 92 - 100 - The impact of the prostaglandin DU+2082 receptor 2 and its downstream effects on the pathophysiology of asthma(2020)
Authors: Christopher E Brightling, Guy Brusselle, Pablo Altman
Pages: 761 - 768 - After asthma : redefining airways diseases(2018)
Authors: Ian D Pavord, Richard Beasley, Alvar Agusti, Gary P Anderson, Elisabeth Bel, Guy Brusselle, Paul Cullinan, Adnan Custovic, Francine M Ducharme, John V Fahy, et al.
Pages: 350 - 400 - Determinants and impact of suboptimal asthma control in Europe: the INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study(2016)
Authors: Fulvio Braido, Guy Brusselle, Daniele Guastalla, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth
- Mepolizumab treatment in patients with severe eosinophilic asthma(2014)
Authors: Hector G Ortega, Mark C Liu, Ian D Pavord, Guy Brusselle, J Mark FitzGerald, Alfredo Chetta, Marc Humbert, Lynn E Katz, Oliver N Keene, Steven W Yancey, et al.
Pages: 1198 - 1207